Schedule 13G ownership disclosure

ANI Pharmaceuticals Inc

Security class unavailable · CUSIP: 00182C103

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
73,388
Percent of class
0.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001628280-18-001719
Form type
SC 13G
Filer
ANI PHARMACEUTICALS INC
CIK
CIK 1023024
Filed
Feb 15, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub